Corcept Therapeutics CORT
NASDAQ CORT
$114.03 -1.21 (-1.05%)
As of: Oct 1, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Shares Outstanding (Diluted) (2014 - 2026)

Updated

Corcept Therapeutics (CORT) posted Shares Outstanding (Diluted) of 118.39 million for Q2 2026, down 1.7% from 120.49 million a year earlier but up 13.4% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends

For FY2025, Corcept Therapeutics' Shares Outstanding (Diluted) came in at 119.99 million, up 5.7% from FY2024.

  • Annual Shares Outstanding (Diluted) shows a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • In prior years, Corcept Therapeutics' Shares Outstanding (Diluted) was 113.48 million in FY2024 (+1.6%), 111.74 million in FY2023 (-3.6%), 115.97 million in FY2022 (-7.9%) and 125.96 million in FY2021 (+1.4%).
  • Quarterly Shares Outstanding (Diluted) has run from a low of 104.44 million in Q1 2026 to a high of 125.96 million in Q4 2021 over five years.
  • On a year-over-year basis, Shares Outstanding (Diluted) increased in six of the last eight quarters, with growth averaging 2.2%.
  • The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q1 2025, with growth of 9.0%; the weakest was Q1 2026, with a decline of 12.8%.
  • According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 104.44 million (Q1 2026), 119.99 million (Q4 2025) and 119.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Corcept Therapeutics 12.46 Bn 11.02 Bn 252.09 Mn 118.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118.39 Mn
Mar 31, 2026 104.44 Mn
Dec 31, 2025 119.99 Mn
Sep 30, 2025 119.44 Mn
Jun 30, 2025 120.49 Mn
Mar 31, 2025 119.82 Mn
Dec 31, 2024 113.48 Mn
Sep 30, 2024 113.72 Mn
Jun 30, 2024 111.24 Mn
Mar 31, 2024 109.92 Mn
Dec 31, 2023 111.74 Mn
Sep 30, 2023 111.10 Mn
Jun 30, 2023 109.59 Mn
Mar 31, 2023 115.43 Mn
Dec 31, 2022 115.97 Mn
Sep 30, 2022 116.62 Mn
Jun 30, 2022 115.40 Mn
Mar 31, 2022 115.04 Mn
Dec 31, 2021 125.96 Mn
Sep 30, 2021 125.14 Mn
API Access

Corcept Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CORT&period=max&api_key=YOUR_API_KEY